Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Acadia Pharmaceutica (NQ: ACAD)
42.25 USD  +0.93 (+2.25%)
Official Closing Price  /  Updated: 7:51 PM EDT, Mar 31, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,282,900
Open 43.52
Bid (Size) 41.50 (10)
Ask (Size) 42.21 (1)
Prev. Close 41.32
Today's Range 41.02 - 44.49
52wk Range 21.56 - 53.70
Shares Outstanding 124,825,969
Dividend Yield N/A
Performance
YTD
+2.77%
+2.77%
1 Month
-3.45%
-3.45%
3 Month
-1.24%
-1.24%
6 Month
+16.68%
+16.68%
1 Year
+56.60%
+56.60%
Top News
More News
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Rare Pediatric Disease Designation for Trofinetide for the Treatment of Rett Syndrome
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) and Neuren Pharmaceuticals Limited (ASX: NEU) announced today that the U.S. Food and Drug Administration (FDA) granted Rare Pediatric Disease (RPD)... Read More
from Business Wire News Releases
10 Small-To-Mid-Cap Biotech Ideas For When The Coronavirus Fades
The COVID-19-induced sell-off has taken a toll on stocks across sectors. An analyst at Cantor Fitzgerald presented his take on how ... Read More
category Covid/19 , Long Ideas , Charles Duncan , and 22 more.
from Benzinga
More News
Read More
Biotech stocks have held up better than the broader market — and these five are potential winners
category SPX , BTAI , ACAD , and 15 more.
from MarketWatch
Notable Monday Option Activity: LE, ACAD, PTCT
category Stocks
from Market News Video
Bullish Moving Average Cross by Acadia Pharmaceu (ACAD)
from Comtex SmarTrend® News Briefs
Interesting ACAD Put And Call Options For May 1st
category Stocks
from Market News Video
Acadia Upgraded To Buy From Neutral At Goldman Sachs
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
ACADIA Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
from Business Wire News Releases
Acadia Pharmaceu Down 11.9% Since SmarTrend Downtrend Call (ACAD)
from Comtex SmarTrend® News Briefs
First Week of April 9th Options Trading For Acadia Pharmaceuticals (ACAD)
category Stocks
from Market News Video
This 1 Stock Is a Good Buy During the Coronavirus Sell-Off
category Market News , ACAD
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.